Status:
COMPLETED
An Integrated Approach to Smoking Cessation in Severe Mental Illness (SMI)
Lead Sponsor:
University of Maryland, Baltimore
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Smoking Cessation
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This 3-year study will involve the design and small-scale clinical trial of a behavioral treatment program for smoking cessation in people with severe mental illness (called Behavioral Treatment for S...
Detailed Description
Smoking is the leading cause of preventable death in the United States, contributing to increased rates of lung cancer and heart disease, and adding complications to other health problems. Over 70% of...
Eligibility Criteria
Inclusion
- Severe and Persistent Mental Illness (schizophrenia, schizoaffective disorder or other severe mental disorder including bipolar disorder, major depression, or severe anxiety disorder).
- Age between 18 and 75 years.
- Current smokers who smoke at least 10 cigarettes per day.
- Must have been seen by a psychiatrist at least every 3 months for the last 6 months.
Exclusion
- Meet criteria for current alcohol/substance dependence (other than nicotine).
- Documented mental retardation, history of severe head injury with LOC, severe and untreated seizure disorder
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2015
Estimated Enrollment :
219 Patients enrolled
Trial Details
Trial ID
NCT00690131
Start Date
August 1 2009
End Date
May 1 2015
Last Update
April 6 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Maryland Baltimore
Baltimore, Maryland, United States, 21201
2
Harbor City Unlimited
Baltimore, Maryland, United States
3
New Ventures, Sheppard Pratt
Timonium, Maryland, United States